1. Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma
   Ram Mohan Ram Kumar et al, 2018, Oncotarget CrossRef
2. De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers
   Yusuke Suenaga et al, 2020, Japanese Journal of Clinical Oncology CrossRef
3. Long noncoding RNAs as tumorigenic factors and therapeutic targets for renal cell carcinoma
   Haiyan Shen et al, 2021, Cancer Cell International CrossRef
4. The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets
   Shaohui Huang et al, 2022, Biomarker Research CrossRef
5. Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN
   Xiyao Shi et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
6. Epigenetic regulation of neuroblastoma development
   Kaat Durinck et al, 2018, Cell and Tissue Research CrossRef
7. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
   Eleanor M. O’Brien et al, 2018, BMC Cancer CrossRef
8. Neuroblastoma Pathogenesis
   Isabelle Janoueix-Lerosey, 2020, Neuroblastoma CrossRef
9. Evaluation of the expression level of some coding and non-coding genes in oral squamous cell carcinoma
   Mohadeseh Ajorlou et al, 2023, Molecular and Cellular Probes CrossRef
10. MYCN in Neuroblastoma: “Old Wine into New Wineskins”
    Maria Braoudaki et al, 2021, Diseases CrossRef
11. MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
    Damiano Bartolucci et al, 2022, Cancers CrossRef
12. The N-Myc-responsive lncRNA MILIP promotes DNA double-strand break repair through non-homologous end joining
    Pei Lin Wang et al, 2022, Proceedings of the National Academy of Sciences CrossRef
13. Non-Coding RNAs in Pediatric Solid Tumors
    Christopher M. Smith et al, 2019, Frontiers in Genetics CrossRef
14. Silencing of the Long Noncoding RNAMYCNOS1Suppresses Activity ofMYCN-Amplified Retinoblastoma WithoutRB1Mutation
    Duangporn Saengwimol et al, 2020, Investigative Opthalmology & Visual Science CrossRef
15. PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective
    Palanisamy Nallasamy et al, 2018, Seminars in Cancer Biology CrossRef
16. Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma
    Omidvar Rezaei et al, 2021, Frontiers in Oncology CrossRef
17. Vessel adherent growth represents a major challenge in the surgical resection of neuroblastoma and Is associated with adverse outcome
    Jakob Mühling et al, 2019, Journal of Pediatric Surgery CrossRef
18. Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets
    Niels Vercouillie et al, 2024, International Journal of Molecular Sciences CrossRef
19. The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers
    Domenica Ronchetti et al, 2024, Cancer Gene Therapy CrossRef
20. Anticancer Effects of I-BET151, an Inhibitor of Bromodomain and Extra-Terminal Domain Proteins
    Jiacheng Lai et al, 2021, Frontiers in Oncology CrossRef
21. Emerging roles of long non-coding RNAs in tumor metabolism
    Hui Sun et al, 2018, Journal of Hematology & Oncology CrossRef
22. Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma
    Jessica L. Bell et al, 2020, International Journal of Molecular Sciences CrossRef
23. Neuroblastoma Epigenetic Landscape: Drugging Opportunities
    Veronica Veschi et al, 2024, Neuroblastoma CrossRef